Suicide in Schizophrenia: Clinical Approaches

  • Robert E. Drake
  • Stephen J. Bartels
  • William C. Torrey


As part of the current trend in suicide research to focus on specific high-risk groups (1), we have been studying suicide in schizophrenia (2–7). In addition to reviewing the literature (2), we have identified risk factors (3–5), considered the influence of depression and hopelessness (6), and examined the differences between attempters and completed suicides (7). This work, along with that of Roy (8) and others (9–15), enables us to identify high-risk patients rather than to predict specific suicides (16).


Suicidal Behavior Schizophrenic Patient Chronic Schizophrenia Medication Side Effect Psychiatric Rehabilitation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hendin H: Suicide: a review of new directions in research. Hosp Community Psychiatry 37: 148–154, 1986.PubMedGoogle Scholar
  2. 2.
    Drake RE, Gates C, Whitaker A, Cotton PG: Suicide among schizophrenics: a review. Compr Psychiatry 26: 90–100, 1985.PubMedCrossRefGoogle Scholar
  3. 3.
    Cotton PG, Drake RE, Gates C: Critical treatment issues in suicide among schizophrenics. Hosp Community Psychiatry 36: 534–536, 1985.PubMedGoogle Scholar
  4. 4.
    Drake RE, Ehrlich J: Suicide attempts associated with akathisia. Am J Psychiatry 142: 499–501, 1985.PubMedGoogle Scholar
  5. 5.
    Drake RE, Gates C, Cotton PG, Whitaker A: Suicide among schizophrenics: who is at risk? J Nery Ment Dis 172: 613–617, 1984.CrossRefGoogle Scholar
  6. 6.
    Drake RE, Cotton PG: Depression, hopelessness, and suicide in chronic schizophrenia. Br J Psychiatry 148: 554–559, 1986.PubMedCrossRefGoogle Scholar
  7. 7.
    Drake RE, Gates C, Cotton PG: Suicide among schizophrenics: a comparison of attempters and completed suicides. Br J Psychiatry 149: 784–787, 1986.PubMedCrossRefGoogle Scholar
  8. 8.
    Roy A: Suicide in chronic schizophrenia. Br J Psychiatry 141: 171–177, 1982.PubMedCrossRefGoogle Scholar
  9. 9.
    Beck AT, Kovacs M, Weissman A: Hopelessness and suicidal behavior: an overview. JAMA 234: 1146–1149, 1975.PubMedCrossRefGoogle Scholar
  10. 10.
    Breier A, Astrachan BM: Characterization of schizophrenic patients who commit suicide. Am J Psychiatry 141: 206–209, 1984.PubMedGoogle Scholar
  11. 11.
    Cohen S, Leonard CV, Farberow NL, Shneidman ES: Tranquilizers and suicide in schizophrenic patients. Arch Gen Psychiatry 11: 312–317, 1964.PubMedCrossRefGoogle Scholar
  12. 12.
    Minkoff K, Bergman E, Beckj AT, Beck R: Hopelessness, depression, and attempted suicide. Am J Psychiatry 130: 455–459, 1973.PubMedGoogle Scholar
  13. 13.
    Planansky K, Johnston R: The occurrence and characteristics of suicidal preoccupation and acts in schizophrenia. Acta Psychiatr Scand 47: 473–483, 1971.PubMedCrossRefGoogle Scholar
  14. 14.
    Shaffer JW, Perlin S, Schmidt CW, Stephens JH: The prediction of suicide in schizophrenics. J Nery Ment Dis 159: 349–355, 1974.CrossRefGoogle Scholar
  15. Warnes H: Suicide in schizophrenics. Dis Nerv Sys 29(suppl 5): 35–40, 1968.Google Scholar
  16. 16.
    Pokorny AD: Prediction of suicide in psychiatric patients. Arch Gen Psychiatry 40: 249–257, 1983.PubMedCrossRefGoogle Scholar
  17. 17.
    Miles CP: Conditions predisposing to suicide. J Nery Ment Dis 164: 455–459, 1977.Google Scholar
  18. 18.
    Niskanen P, Lonnquist J, Achte KA: Schizophrenia and suicide. Psychiatr Fenn 223–227, 1973.Google Scholar
  19. 19.
    Planansky K, Johnston R: Clinical setting and motivation in suicide attempts. Acta Psychiatr Scand 49: 680–690, 1973.PubMedCrossRefGoogle Scholar
  20. 20.
    Drake RE, Wallach MA: Mental patients’ attitudes toward psychiatric hospitalization: a neglected aspect of hospital tenure. Am J Psychiatry 145: 29–34, 1988.PubMedGoogle Scholar
  21. 21.
    Roy A: Suicide in schizophrenia, in Suicide. Edited by Q. Roy Baltimore, Williams and Wilkins, 1986.Google Scholar
  22. 22.
    Bleuler E: Dementia Praecox or the Group of Schizophrenias. New York, International Universities Press, 1950.Google Scholar
  23. 23.
    Bartels SJ, Drake RE: Depressive symptoms in schizophrenia: a comprehensive differential diagnosis. Compr Psychiatry in press.Google Scholar
  24. 24.
    Talbott JA, Glick ID: The inpatient care of the chronically mentally ill. Schizophr Bull 12: 129–140, 1986.PubMedCrossRefGoogle Scholar
  25. 25.
    Mandel MR, Severe JB, Schooler NR et al: Development and prediction of postpsychotic depression in neuroleptic treated schizophrenics. Arch Gen Psychiatry 39: 197–203, 1982.Google Scholar
  26. 26.
    Siris SG, Harmon GK, Endicott J: Postpsychotic depressive symptoms in hospitalized schizophrenic patients. Arch Gen Psychiatry 38: 1122–1123, 1981.PubMedCrossRefGoogle Scholar
  27. 27.
    Gunderson JG: Defining the therapeutic processes in psychiatric milieus. Psychiatry 41: 327–335, 1978.PubMedGoogle Scholar
  28. 28.
    Farberow NL: Suicide prevention in the hospital. Hosp Community Psychiatry 32: 99–104, 1981.PubMedGoogle Scholar
  29. 29.
    Olin HS: Management precautions for surviving patients after a ward suicide. Hosp Community Psychiatry 31: 348–349, 1980.PubMedGoogle Scholar
  30. 30.
    Sletten IW, Brown ML, Evenson RC, Altman H: Suicide in mental hospital patients. Dis Nerv Sys 33: 328–334, 1972.Google Scholar
  31. 31.
    Drake RE, Sederer LI: Inpatient psychosocial treatment of chronic schizophrenia: Negative effects and current guidelines. Hosp Community Psychiatry 37: 897–901, 1986.PubMedGoogle Scholar
  32. 32.
    Knights A, Hirsch SR: Revealed depression and drug treatment for schizophrenia. Arch Gen Psychiatry 38: 806–811, 1981.PubMedCrossRefGoogle Scholar
  33. 33.
    Breier A, Strauss JS: The role of social relationships in the recovery from psychotic disorders. Am J Psychiatry 141: 949–955, 1984.PubMedGoogle Scholar
  34. 34.
    Herz M: Prodromal symptoms and prevention of relapse in schizophrenia. J Clin Psychiatry 46: 22–25, 1985.PubMedGoogle Scholar
  35. 35.
    Eichelman B: Toward a rational pharmacotherapy for aggressive and violent behavior. Hosp Community Psychiatry 39: 31Google Scholar
  36. 36.
    Martin RL, Cloninger CR, Guze SB: Frequency and differential diagnosis of depressive syndromes in schizophrenia. J Clin Psychiatry 46: 9–13, 1985.PubMedGoogle Scholar
  37. 37.
    Siris SG, Morgan V, Fagerstrom R et al: Adjunctive imipramine in the treatment of postpsychotic depression. Arch Gen Psychiatry 44: 533–539, 1987.PubMedCrossRefGoogle Scholar
  38. 38.
    Siris SG, Adam F, Cohen M et al: Targeted treatment of depression-like symptoms in schizophrenia. Psychopharm Bull 23: 85–89, 1987.Google Scholar
  39. 39.
    Drake RE, Osher FC, Wallach MA: Alcohol use and abuse in schizophrenia: a prospective community study. J Nery Ment Dis in press.Google Scholar
  40. 40.
    Brandon S, Cowley P, McDonald C et al: Leicester ECT trial: Results in Schizophrenia. Br J Psychiatry 146: 177–183, 1985.PubMedCrossRefGoogle Scholar
  41. 41.
    Salzman C: The use of ECT in the treatment of schizophrenia. Am J Psychiatry 137: 1032–1041, 1980.PubMedGoogle Scholar
  42. 42.
    Abrams R: Electroconvulsive Therapy. New York, Oxford University Press, 1988.Google Scholar
  43. 43.
    Schulte JR: Homicide and suicide associated with akathisia and haloperidol. Am J For Psychiatry 6: 3–7, 1985.Google Scholar
  44. 44.
    Shear K, Frances A, Weiden P: Suicide associated with akathisia and depot fluphenazine treatment. J Clin Psychopharm 3: 235–236, 1983.CrossRefGoogle Scholar
  45. 45.
    Tucker GJ, Price RP, Johnson VB, McCallister T: Phenomenology of temporal lobe dysfunctions: a link to atypical psychosis–a series of cases. J Nery Ment Dis 174: 348–356, 1986.CrossRefGoogle Scholar
  46. 46.
    Convit A, Jaeger J, Lin SP et al: Predicting assaultiveness in psychiatric inpatients: a pilot study. Hosp Community Psychiatry 39: 429–434, 1988.PubMedGoogle Scholar
  47. 47.
    Krakowski M, Volavka J, Brizer D: Psychopathological violence: a review of the literature. Compr Psychiatry 27: 131–148, 1986.PubMedCrossRefGoogle Scholar
  48. 48.
    Tardiff K, Sweillam A: Assault, suicide and mental illness. Arch Gen Psychiatry 37: 164–169, 1980.PubMedCrossRefGoogle Scholar
  49. 49.
    Mann JJ: Psychobiologic predictors of suicide. J Clin Psychiatry 48 (12, Suppl): 39–43, 1987.PubMedGoogle Scholar
  50. 50.
    Ninan PT, van Kammen DP, Scheinen M et al: CSF 5hydroxyindoleacetic acid levels in suicidal schizophrenic patients. Am J Psychiatry 141: 566–569, 1984.PubMedGoogle Scholar
  51. 51.
    van Praag HM: CSF 5-HIAA and suicide in non-depressed schizophrenics. Lancet 2: 977–978, 1983.PubMedCrossRefGoogle Scholar
  52. 52.
    Kalina RK: Diazepam: its role in a prison setting. Dis Nery Sys 25: 101–107, 1964.Google Scholar
  53. 53.
    Salzman C, Green AL, Rodriguez-Villa F, Jaskin G: Benzodiazepines combined with neuroleptics in the management of severe disruptive behavior. Psychosomatics 27: 17–21, 1986.PubMedCrossRefGoogle Scholar
  54. 54.
    Sorgi PJ, Ratey JJ, Polakoff S: Beta-adrenergic blockers for control of aggressive behaviors in patients with chronic schizophrenia. Am J Psychiatry 143: 775776, 1986.Google Scholar
  55. 55.
    Tupin JP, Smith DB, Classon TL et al: Long-term use of lithium in aggressive prisoners. Compr Psychiatry 14: 311–317, 1973.PubMedCrossRefGoogle Scholar
  56. 56.
    Morand C, Young CN, Ervin FR: Clinical response of aggressive schizophrenics to oral tryptophan. Biol Psychiatry 18: 575–578, 1983.PubMedGoogle Scholar
  57. 57.
    Hakola HP, Laulumaa VA: Carbamazepine in the treatment of violent schizophrenics. Lancet 1: 1358, 1982.PubMedCrossRefGoogle Scholar
  58. 58.
    Klein E, Bental E, Lerer B et al: Carbamazepine and haloperidol vs. placebo and haloperidol in excited psychoses. Arch Gen Psychiatry 41: 165–170, 1984.PubMedCrossRefGoogle Scholar
  59. 59.
    Monroe RJ: Anticonvulsants in the treatment of schizophrenia. J Nery Ment Dis 160: 119–126, 1975.CrossRefGoogle Scholar
  60. 60.
    Keats MM, Mukherjee S: Antiaggressive effect of adjunctive clonazepam in schizophrenia associated with seizure disorder. J Clin Psychiatry 49: 117–118, 1988.PubMedGoogle Scholar
  61. 61.
    Klein DF, Gittleman R, Quitkin F, Rifkin A: Diagnosis and Drug Treatment of Psychiatric Disorders: Adults and Children. Baltimore, Williams and Wilkins, 1980.Google Scholar
  62. 62.
    Frank JD: Persuasion and Healing. New York, Schocken Books, 1974.Google Scholar
  63. 63.
    Semrad EV: Teaching Psychotherapy of Psychotic Patients. New York, Grune and Stratton, 1969.Google Scholar
  64. 64.
    Gunderson JG, Frank AF, Katz HM et al: Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophr Bull 10: 564–598, 1984 65. Virkkunen M: Attitude toward psychiatric treatment before suicide in schizophrenia. Br J Psychiatry 128: 47–49, 1976.CrossRefGoogle Scholar
  65. 66.
    Harris M, Bergman HC: Case management with the chronically mentally ill: a clinical perspective. Am J Orthopsychiatry 57: 296–302, 1987.PubMedCrossRefGoogle Scholar
  66. 67.
    Buie DH, Maltsberger JT: The Practical Formulation of Suicide Risk. Cambridge, Ma, Firefly Press, 1983.Google Scholar
  67. 68.
    Havens L: Making Contact: Uses of Language in Psychotherapy. Cambridge, Ma, Harvard University Press, 1986.Google Scholar
  68. 69.
    Lamb HR: Young adult chronic patients: the new drifters. Hosp Community Psychiatry 33: 465–486, 1982.PubMedGoogle Scholar
  69. 70.
    Bibring E: The mechanism of depression, in Affective Disorders: Psychoanalytic Contribution to their Study. Ed. Greenacre P, New York, International Universities Press, 1953.Google Scholar
  70. 71.
    Weisman A: The Coping Capacity: On the Nature of Being Mortal. New York, Human Sciences Press, 1984.Google Scholar
  71. 72.
    Heavens L: Approaches to the Mind. Boston, Little, Brown, Inc. 1973.Google Scholar
  72. 73.
    Group for the Advancement of Psychiatry: Report No. 119. A Family Affair. Helping Families Cope with Mental Illness: A guide for the Professions. New York, Brunner/Mazel, 1986.Google Scholar
  73. 74.
    Raymond ME, Slaby AE, Lieb J: Familial response to mental illness. Social Casework 56: 492–496, 1975.Google Scholar
  74. 75.
    Smyer MA, Birkel RC: Interventions with families of the chronically mentally ill elderly, in The Chronically Mentally Ill Elderly: Directions for Research. Ed. Light E, Lebowitz B. Washington, DC, Government Printing Office, in press.Google Scholar
  75. 76.
    Terkelson KG: The evolution of family responses to mental illness through time, in Families of the Mentally ILL: Coping and Adaptation. Ed. Hatfield AB, Lefley HP, New York, Guilford, 1987.Google Scholar
  76. 77.
    Tessler RC, Killian LM, Gubman GC: Stages in family response to mental illness: an ideal type. Psychosoc Rehab J 10: 3–16, 1987.Google Scholar
  77. 78.
    Anderson CM, Reiss DJ, Hogarty GE: Schizophrenia and the Family: A Practitioner’s Guide to Psychoeducation and Management. New York, Guilford Press, 1986.Google Scholar
  78. 79.
    Bernheim KF, Lehman AF: Working with Families of the Mentally Ill. New York, W.W. Norton, 1985.Google Scholar
  79. 80.
    Falloon IRH, Boyd JL, McGill CW: Family Care of Schizophrenia. New York, Guilford Press, 1984.Google Scholar
  80. 81.
    Wing JK: Rehabilitation and management of schizophrenia, in Handbook of Psychiatry 3; Psychosis of Uncertain Aetiology. Edited by Wing JK, Wing L. New York, Cambridge University Press, 1982.Google Scholar
  81. 81.
    Wing JK: Rehabilitation and management of schizophrenia, in Handbook of Psychiatry 3; Psychosis of Uncertain Aetiology. Edited by Wing JK, Wing L. New York, Cambridge University Press, 1982.Google Scholar
  82. 82.
    Anthony WA, Cohen MR, Cohen BF: Philosophy, treatment process, and principles of the psychiatric rehabilitation approach, in Deinstitutionalization. Edited by Bachrach L, San Francisco, Jossey-Bass, 1983.Google Scholar
  83. 83.
    Stone AA, Eldred SH: Delusional formation during the activation of chronic schizophrenic patients. Arch Gen Psychiatry 1: 177–179, 1959.CrossRefGoogle Scholar
  84. 84.
    Wing JK, Bennett DH, Denham J: The industrial rehabilitation of long-stay schizophrenic patients, in Medical Research Council Research Memorandum No. 42 London, HMSO, 1964.Google Scholar
  85. 85.
    Hewett S, Ryan P, Wing JK: Living without the mental hospitals. J Soc Policy 4: 391–404, 1975.CrossRefGoogle Scholar
  86. 86.
    Harding CM, Zubin J, Strauss JS: Chronicity in schizophrenia: fact, partial fact, or artifact? Host) Community Psychiatry 38: 477–486, 1987.Google Scholar
  87. 87.
    Lovejoy M: Recovery from schizophrenia: a personal odyssey, in The Chronic Mental Patient/II. Edited by Menninger WW, Hannah G, Washington, American Psychiatric Press, 1987.Google Scholar
  88. 88.
    Struass JS: Discussion: what does rehabilitation accomplish? Schizophr Bull 12: 720–723, 1986.CrossRefGoogle Scholar
  89. 1.
    Robins E, Murphy GE, Wilkinson RH, Gassner S, Kayes J: Some clinical considerations in the prevention of suicide based on a study of successful suicides. Am J of Public Health 49: 888-889, 1959.Google Scholar
  90. 2.
    Barraclough BM, Bunch J, Nelson B, Sainsbury P: A hundred cases of suicide: clinical aspects. Br J Psychiatry 125: 355, 1974.Google Scholar
  91. 3.
    Shifi M, Carrigan S, Whitt.inghill JR, Derick, R: Psychological autopsy of completed suicide in children and adolescents. Am J Psychiatry, 142: 1061-1064, 1985.Google Scholar
  92. 4.
    Rich CL, Fowler RL, Young D: San Diego Suicide Study I: Young vs. Old Subjects. Arch Gen Psychiatry 43 (6): 577-582, 1986a.Google Scholar
  93. 5.
    Rich CL, Fowler RL, Young D: Suicide and Psychosis: Changing patterns. Proceedings, American Association of Suicidology, 19th Annual Meeting, Atlanta, GA, p. 94-95, 1986b.Google Scholar
  94. 6.
    Brent DA, Perper JA, Goldstein CE, Kolko DJ, Allan MJ, Allman CJ, Zelenak JP: Risk factors for adolescent suicide. Arch Gen Psychiatry, 45 (6): 581-588, 1988.Google Scholar
  95. 7.
    Osmond H, Hoffer A: Schizophrenia and suicide. J Schizophrenia 1 (1): 54-64, 1967.Google Scholar
  96. 8.
    Miles CP: Conditions predisposing to suicide: a review. J Nery Ment Dis 164: 231-246, 1977.Google Scholar
  97. 9.
    Drake RE, Gates C, Cotton PG, Whitaker A: Suicide among schizophrenics: who is at risk? J Nery Ment Dis 176: 613-617, 1984.Google Scholar
  98. 10.
    Cotton PG, Drake RE, Gates C: Critical treatment issues in suicide among schizophrenics. Hosp Commun Psychiatry 36: 534-536, 1985.Google Scholar
  99. 11.
    Drake RE, Cotton PG: Depression, hopelessness, and suicide in chronic schizophrenia. Br J Psychiatry 148: 554-559, 1986.Google Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • Robert E. Drake
    • 1
  • Stephen J. Bartels
    • 1
  • William C. Torrey
    • 1
  1. 1.Dartmouth Medical SchoolHanoverGermany

Personalised recommendations